CorMedix Inc
CRMD10.080USD
-0.530-5.00%
終値 10/16, 16:00（ET）15分遅れの株価
752.18M時価総額
14.70直近12ヶ月PER
詳細情報 CorMedix Inc 企業名
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
CorMedix Incの企業情報
企業コードCRMD
会社名CorMedix Inc
上場日Mar 25, 2010
最高経営責任者「CEO」Mr. Joseph Todisco
従業員数64
証券種類Ordinary Share
決算期末Mar 25
本社所在地300 Connell Drive
都市BERKELEY HEIGHTS
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号07922
電話番号19085179500
ウェブサイトhttps://cormedix.com/
企業コードCRMD
上場日Mar 25, 2010
最高経営責任者「CEO」Mr. Joseph Todisco
CorMedix Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph Todisco
Mr. Joseph Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
302.20K
--
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-3.77%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
69.69K
--
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
53.47K
-31.86%
Ms. Erin Mistry
Ms. Erin Mistry
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
29.12K
-54.14%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
13.33K
--
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
11.00K
-69.44%
Mr. Dan Ferry
Mr. Dan Ferry
IR Contact Officer
IR Contact Officer
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
Ms. Elizabeth (Liz) Massonhurlburt
Ms. Elizabeth (Liz) Massonhurlburt
Chief Operating Officer
Chief Operating Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph Todisco
Mr. Joseph Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
302.20K
--
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-3.77%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
69.69K
--
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
53.47K
-31.86%
Ms. Erin Mistry
Ms. Erin Mistry
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
29.12K
-54.14%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
13.33K
--
収益内訳
FY2025Q2
FY2025Q1
FY2024
データなし
地域別USD
会社名
収益
比率
United States
39.74M
0.00%
事業別
地域別
データなし
株主
更新時刻: Sun, Sep 14
更新時刻: Sun, Sep 14
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
6.42%
Abdalkader (Shaibatalhamd Aymen)
6.22%
The Vanguard Group, Inc.
5.77%
Marshall Wace LLP
3.46%
Citadel Advisors LLC
2.30%
他の
75.83%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
6.42%
Abdalkader (Shaibatalhamd Aymen)
6.22%
The Vanguard Group, Inc.
5.77%
Marshall Wace LLP
3.46%
Citadel Advisors LLC
2.30%
他の
75.83%
種類
株主統計
比率
Investment Advisor
22.74%
Investment Advisor/Hedge Fund
13.43%
Hedge Fund
8.73%
Individual Investor
7.55%
Research Firm
1.48%
Pension Fund
0.63%
Bank and Trust
0.28%
Venture Capital
0.06%
Insurance Company
0.03%
他の
45.06%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
298
35.12M
47.05%
+4.14M
2025Q2
280
26.40M
35.51%
-7.69M
2025Q1
281
29.73M
44.27%
-179.25K
2024Q4
252
24.74M
40.82%
-30.08K
2024Q3
228
19.79M
34.25%
-1.78M
2024Q2
217
17.74M
32.28%
-4.09M
2024Q1
218
17.92M
32.60%
-5.73M
2023Q4
217
19.38M
35.35%
-2.82M
2023Q3
208
18.46M
33.68%
-3.54M
2023Q2
197
19.74M
38.10%
+6.18M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
4.80M
6.42%
+485.88K
+11.27%
Jun 30, 2025
Abdalkader (Shaibatalhamd Aymen)
4.65M
6.22%
+4.65M
--
Aug 08, 2025
The Vanguard Group, Inc.
4.31M
5.77%
+675.49K
+18.59%
Jun 30, 2025
Marshall Wace LLP
2.58M
3.46%
+2.35M
+1019.17%
Jun 30, 2025
Citadel Advisors LLC
1.71M
2.3%
+1.61M
+1517.64%
Jun 30, 2025
State Street Investment Management (US)
1.60M
2.15%
+62.52K
+4.06%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.60M
2.14%
+163.40K
+11.40%
Jun 30, 2025
Nuveen LLC
1.45M
1.94%
+1.27M
+740.45%
Jun 30, 2025
Alyeska Investment Group, L.P.
750.00K
1%
+750.00K
--
Jun 30, 2025
Ghisallo Capital Management LLC
750.00K
1%
+750.00K
--
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Mon, Oct 6
更新時刻: Mon, Oct 6
銘柄名
比率
Invesco Dorsey Wright Healthcare Momentum ETF
2.14%
SPDR S&P Pharmaceuticals ETF
1.45%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.05%
First Trust Active Factor Small Cap ETF
0.44%
Janus Henderson Small Cap Growth Alpha ETF
0.32%
iShares Micro-Cap ETF
0.2%
Vanguard US Multifactor ETF
0.16%
Vanguard US Momentum Factor ETF
0.13%
Principal U.S. Small-Cap ETF
0.12%
Fidelity Small-Mid Multifactor ETF
0.12%
詳細を見る
Invesco Dorsey Wright Healthcare Momentum ETF
比率2.14%
SPDR S&P Pharmaceuticals ETF
比率1.45%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率1.05%
First Trust Active Factor Small Cap ETF
比率0.44%
Janus Henderson Small Cap Growth Alpha ETF
比率0.32%
iShares Micro-Cap ETF
比率0.2%
Vanguard US Multifactor ETF
比率0.16%
Vanguard US Momentum Factor ETF
比率0.13%
Principal U.S. Small-Cap ETF
比率0.12%
Fidelity Small-Mid Multifactor ETF
比率0.12%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
